News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
664,258 Results
Type
Article (50934)
Company Profile (336)
Press Release (612988)
Section
Business (190415)
Career Advice (2314)
Deals (33778)
Drug Delivery (119)
Drug Development (80295)
Employer Resources (137)
FDA (16493)
Job Trends (15027)
News (329870)
Policy (32874)
Tag
Academia (2626)
Alliances (47616)
Alzheimer's disease (1284)
Approvals (16441)
Artificial intelligence (183)
Bankruptcy (303)
Best Places to Work (11598)
Biotechnology (215)
Breast cancer (217)
Cancer (1578)
Cardiovascular disease (136)
Career advice (1922)
CAR-T (121)
Cell therapy (333)
Clinical research (64547)
Collaboration (581)
Compensation (290)
COVID-19 (2498)
C-suite (146)
Data (1470)
Diabetes (200)
Diagnostics (5806)
Earnings (72404)
Employer resources (123)
Events (103445)
Executive appointments (509)
FDA (17291)
Funding (510)
Gene therapy (231)
GLP-1 (717)
Government (4569)
Healthcare (19097)
Infectious disease (2598)
Inflammatory bowel disease (126)
Interviews (406)
IPO (15212)
Job creations (3893)
Job search strategy (1652)
Layoffs (433)
Legal (7523)
Lung cancer (243)
Manufacturing (227)
Medical device (13875)
Medtech (13880)
Mergers & acquisitions (18844)
Metabolic disorders (557)
Neuroscience (1669)
NextGen: Class of 2025 (6561)
Non-profit (4429)
Northern California (1835)
Obesity (322)
Opinion (245)
Patents (130)
People (57357)
Phase I (20679)
Phase II (28079)
Phase III (21111)
Pipeline (614)
Postmarket research (2584)
Preclinical (8135)
Radiopharmaceuticals (257)
Rare diseases (300)
Real estate (5745)
Regulatory (22425)
Research institute (2383)
Resumes & cover letters (354)
Southern California (1543)
Startups (3616)
United States (16442)
Vaccines (602)
Weight loss (250)
Date
Today (135)
Last 7 days (399)
Last 30 days (1972)
Last 365 days (34985)
2025 (1767)
2024 (35387)
2023 (40065)
2022 (50662)
2021 (54589)
2020 (52932)
2019 (46364)
2018 (35173)
2017 (32504)
2016 (31678)
2015 (36522)
2014 (29168)
2013 (24825)
2012 (26637)
2011 (26881)
2010 (25796)
Location
Africa (839)
Arizona (159)
Asia (41365)
Australia (6710)
California (4125)
Canada (1470)
China (364)
Colorado (196)
Connecticut (215)
Europe (89437)
Florida (588)
Georgia (144)
Illinois (446)
Indiana (257)
Maryland (711)
Massachusetts (3310)
Michigan (153)
Minnesota (312)
New Jersey (1184)
New York (1148)
North Carolina (867)
Northern California (1835)
Ohio (143)
Pennsylvania (970)
South America (1181)
Southern California (1543)
Texas (597)
Utah (119)
Washington State (417)
664,258 Results for "i med pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
·
5 min read
·
Annalee Armstrong
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Editorial
The People Behind Biopharma’s Big Wins: Personal Stories From JPM25
As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and pharma executives—and the general comradery in the air throughout the chaotic event.
January 17, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
November 26, 2024
·
3 min read
Press Releases
Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927
November 5, 2024
·
1 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Press Releases
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
December 29, 2024
·
6 min read
1 of 66,426
Next
